RMRK Stock Overview
Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rimrock Gold Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.0012 |
| 52 Week Low | US$0.0003 |
| Beta | 0 |
| 11 Month Change | -25.00% |
| 3 Month Change | 0% |
| 1 Year Change | -57.14% |
| 33 Year Change | -78.57% |
| 5 Year Change | 50.00% |
| Change since IPO | -99.95% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| RMRK | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.6% | 0.5% |
| 1Y | -57.1% | 13.1% | 30.7% |
Return vs Industry: RMRK underperformed the US Pharmaceuticals industry which returned 13.1% over the past year.
Return vs Market: RMRK underperformed the US Market which returned 30.7% over the past year.
Price Volatility
| RMRK volatility | |
|---|---|
| RMRK Average Weekly Movement | 36.6% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RMRK's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RMRK's weekly volatility has increased from 29% to 37% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Jordan Starkman | www.rimrockgold.com |
Rimrock Gold Corp., through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts. The company was incorporated in 2007 and is based in Las Vegas, Nevada.
Rimrock Gold Corp. Fundamentals Summary
| RMRK fundamental statistics | |
|---|---|
| Market cap | US$865.21k |
| Earnings (TTM) | -US$764.61k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs RMRK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMRK income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$161.40k |
| Gross Profit | -US$161.40k |
| Other Expenses | US$603.21k |
| Earnings | -US$764.61k |
Last Reported Earnings
May 31, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did RMRK perform over the long term?
See historical performance and comparison